Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group

Transplantation

Volumn 88, Issue 5, 2009, Pages 614-619

  Dahlke, Marc H ^a   Hoogduijn, Martin ^b   Eggenhofer, Elke ^a   Popp, Felix C ^a   Renner, Philipp ^a   Slowik, Przemyslaw ^a   Rosenauer, Agnes ^a   Piso, Pompiliu ^a   Geissler, Edward K ^a   Lange, Claudia ^c   Chabannes, Dominique ^d   Mazzanti, Benedetta ^e   Bigenzahn, Sinda ^f   Bertolino, Patrick ^g   Kunter, Uta ^h   Introna, Martino ⁱ   Rambaldi, Alessandro ⁱ   Capelli, Chiara ⁱ   Perico, Norberto ^j   Casiraghi, Federica ^j   Noris, Marina ^j   Gotti, Eliana ^j   Seifert, Martina ^k   Saccardi, Riccardo ^e   Verspaget, Hein W ^l   Van Hoek, Bart ^l   Bartholomew, Amelia ^m   Wekerle, Thomas ^f   Volk, Hans D ^k   Remuzzi, Giuseppe ^j   Deans, Robert ⁿ   Lazarus, Hillard ^o   Schlitt, Hans J ^a   Baan, Carla C ^b   more..

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Institut de Transplantation et de Recherche en Transplantation (ITERT)   (France)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF SYDNEY   (Australia)

^h UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

ⁱ OSPEDALI RIUNITI   (Italy)

^j MARIO NEGRI INST PHARMACOL RES   (Italy)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁿ ATHERSYS INC   (United States)

^o UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

Cell therapy; Mesenchymal stem cells; MISOT; Position paper; Solid organ transplantation

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; IMMUNOSUPPRESSIVE AGENT;

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL ISOLATION; CELL REGENERATION; CONFERENCE PAPER; FIBROBLAST; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL ETHICS; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; STEM CELL EXPANSION; ANIMAL; ARTICLE; BIOLOGICAL THERAPY; METHODOLOGY;

ANIMALS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONORS; MESENCHYMAL STEM CELL TRANSPLANTATION; ORGAN TRANSPLANTATION; TISSUE THERAPY;

EID: 70349576348     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b4425a     Document Type: Conference Paper

References (54)

1. 1. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393. (Pubitemid 41671625)
2. 2. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315. (Pubitemid 44269669)
3. Hung SC, Pochampally RR, Hsu SC, et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2007; 2: e416.
4. Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 2008; 38: 1745.
5. 5. Smith JR, Pochampally R, Perry A, et al. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 2004; 22: 823. (Pubitemid 39166939)
6. 6. Capelli C, Domenghini M, Borleri G, et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 2007; 40: 785. (Pubitemid 47521539)
7. 7. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119(Pt 11): 2204. (Pubitemid 43960310)
8. Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev 2006; 15: 49.
9. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15: 1794.
10. 10. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279. (Pubitemid 35471185)
11. 11. Toma JG, McKenzie IA, Bagli D, et al. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005; 23: 727. (Pubitemid 40791788)
12. 12. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294. (Pubitemid 44464698)
13. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
14. 14. Beggs KJ, Lyubimov A, Borneman JN, et al. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal, stem cells to baboons. Cell Transplant 2006; 15: 711. (Pubitemid 46095254)
15. Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21: 1733.
16. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371: 1579.
17. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004; 62: 489.
18. von Bonin M, Stolzel F, Goedecke A, et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 2009; 43: 245.
19. 19. Lange C, Cakiroglu F, Spiess AN, et al. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 2007; 213: 18. (Pubitemid 47378788)
20. Aslam R, Speck ER, Kim M, et al. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion 2008; 48: 1778.
21. 21. Hopkins LM, Davis JM, Buchli R, et al. MHC class I-associated peptides identified from normal platelets and from individuals with idiopathic thrombocytopenic purpura. Hum Immunol 2005; 66: 874. (Pubitemid 41416532)
22. Semple JW, Speck ER, Milev YP, et al. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation. Blood 1995; 86: 805.
23. Le Blanc K, Samuelsson H, Lonnies L, et al. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 2007; 84: 1055.
24. 24. Krampera M, Cosmi L, Angeli R, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386. (Pubitemid 44464808)
25. Casiraghi F, Azzollini. N, Cassis P, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a scmiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933.
26. Chabannes D, Hill M, Merieau E, et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007; 110: 3691.
27. Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can induce long-term, acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20: 55.
28. Sbano P, Cuccia A, Mazzanti B, et al. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res 2008; 300: 115.
29. Liska V, Slowik P, Eggenhofer E, et al. Intraportal injection of porcine multipotent mesenchymal stromal cells augments liver regeneration after portal vein embolization. In Vivo 2009; 23: 229.
30. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLAidentical sibling culture-expanded mesenchymal stem, cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389.
31. 31. Kunter U, Rong S, Boor P, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007; 18: 1754. (Pubitemid 46870312)
32. 32. Kunter U, Rong S, Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. JAm Soc Nephrol 2006; 17: 2202. (Pubitemid 44141910)
33. Di Ianni M, Del Papa B, De Ioanni M, et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 2008; 36: 309.
34. 34. Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005; 90: 516. (Pubitemid 40592895)
35. 35. Prevosto C, Zancolli M, Canevali P, et al. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 2007; 92: 881. (Pubitemid 350144234)
36. 36. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353. (Pubitemid 351159234)
37. 37. Inoue S, Popp FC, Koehl GE, et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589. (Pubitemid 43890897)
38. Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362.
39. Wu GD, Nolta JA, Jin YS, et al. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003; 75: 679.
40. 40. di Bonzo LV, Ferrero I, Cravanzola C, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008; 57: 223. (Pubitemid 351158051)
41. Lazennec G, Jorgensen C. Concise review: Adult multipotent stromal cells and cancer: Risk or benefit? Stem Cells 2008; 26: 1387.
42. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557.
43. 43. Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008; 16: 571. (Pubitemid 351314998)
44. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009; 4: 206.
45. Mouiseddine M, Francois S, Semont A, et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007; 80(Spec No1): S49.
46. Molloy AP, Martin FT, Dwyer RM, et al. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer 2009; 124: 326.
47. Karlsson H, Samarasinghe S, Ball LM, et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 2008; 112: 532.
48. Ren YX, Finckenstein FG, Abdueva DA, et al. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res 2008; 68: 6587.
49. Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy. Cell Cycle 2007; 6: 2884.
50. Alfaro MP, Pagni M, Vincent A, et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA 2008; 105: 18366.
51. 51. Ringden O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271. (Pubitemid 350011699)
52. Hoogduijn MJ, Crop MJ, Peeters AM, et al. Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant 2009; 9: 222.
53. Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: Possible mechanisms. Regen Med 2008; 3: 531.
54. Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can affect solid organ allograft survival. Transplantation 2009; 87(9 Suppl): S57.